Jin David 4
4 · Fortress Biotech, Inc. · Filed Oct 1, 2024
Insider Transaction Report
Form 4
Jin David
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.001
2024-10-01$1.23/sh+2,625$3,224→ 240,893 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Total holdings include 230,000 shares underlying deferred restricted stock units.